OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

C.h. Brahe; S. Krabbe; M. Østergaard; L. Ørnbjerg; D. Glinatsi; H. Røgind; H.S. Jensen; A. Hansen; J. Nørregaard; S. Jacobsen; L. Terslev; T.k. Huynh; D.v. Jensen; N. Manilo; K. Asmussen; P.b. Frandsen; M. Boesen; Z. Rastiemadabadi; L. M. Carlsen; J. Møller; N.s. Krogh; M.l. Hetland

doi:10.1136/annrheumdis-2018-eular.2901

OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

C.h. Brahe, S. Krabbe, M. Østergaard, L. Ørnbjerg, D. Glinatsi, H. Røgind, H.S. Jensen, A. Hansen, J. Nørregaard, S. Jacobsen, L. Terslev, T.k. Huynh, D.v. Jensen, N. Manilo, K. Asmussen, P.b. Frandsen, M. Boesen, Z. Rastiemadabadi, L. M. Carlsen, J. MøllerN.s. Krogh, M.l. Hetland

Institut for Klinisk Medicin

Originalsprog	Engelsk
Publikationsdato	2018
Antal sider	2
DOI	https://doi.org/10.1136/annrheumdis-2018-eular.2901
Status	Udgivet - 2018

Adgang til dokumentet

10.1136/annrheumdis-2018-eular.2901

70.2.full.pdfForlagets udgivne version, 608 KB

Citationsformater

Brahe, C. H., Krabbe, S., Østergaard, M., Ørnbjerg, L., Glinatsi, D., Røgind, H., Jensen, H. S., Hansen, A., Nørregaard, J., Jacobsen, S., Terslev, L., Huynh, T. K., Jensen, D. V., Manilo, N., Asmussen, K., Frandsen, P. B., Boesen, M., Rastiemadabadi, Z., Carlsen, L. M., ... Hetland, M. L. (2018). OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors. 70-71. https://doi.org/10.1136/annrheumdis-2018-eular.2901

Brahe, CH, Krabbe, S, Østergaard, M, Ørnbjerg, L, Glinatsi, D, Røgind, H, Jensen, HS, Hansen, A, Nørregaard, J, Jacobsen, S, Terslev, L, Huynh, TK, Jensen, DV, Manilo, N, Asmussen, K, Frandsen, PB, Boesen, M, Rastiemadabadi, Z, Carlsen, LM, Møller, J, Krogh, NS & Hetland, ML 2018, 'OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors', s. 70-71. https://doi.org/10.1136/annrheumdis-2018-eular.2901

@conference{fb11fba86c864f15a3a1719584e37864,

title = "OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors",

author = "C.h. Brahe and S. Krabbe and M. {\O}stergaard and L. {\O}rnbjerg and D. Glinatsi and H. R{\o}gind and H.S. Jensen and A. Hansen and J. N{\o}rregaard and S. Jacobsen and L. Terslev and T.k. Huynh and D.v. Jensen and N. Manilo and K. Asmussen and P.b. Frandsen and M. Boesen and Z. Rastiemadabadi and Carlsen, {L. M.} and J. M{\o}ller and N.s. Krogh and M.l. Hetland",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.2901",

language = "English",

pages = "70--71",

}

TY - ABST

T1 - OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

AU - Brahe, C.h.

AU - Krabbe, S.

AU - Østergaard, M.

AU - Ørnbjerg, L.

AU - Glinatsi, D.

AU - Røgind, H.

AU - Jensen, H.S.

AU - Hansen, A.

AU - Nørregaard, J.

AU - Jacobsen, S.

AU - Terslev, L.

AU - Huynh, T.k.

AU - Jensen, D.v.

AU - Manilo, N.

AU - Asmussen, K.

AU - Frandsen, P.b.

AU - Boesen, M.

AU - Rastiemadabadi, Z.

AU - Carlsen, L. M.

AU - Møller, J.

AU - Krogh, N.s.

AU - Hetland, M.l.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.2901

DO - 10.1136/annrheumdis-2018-eular.2901

M3 - Conference abstract for conference

SP - 70

EP - 71

ER -